Non-interventional Study of Patients with Transthyretin (ATTR) Amyloidosis

Trial Identifier:	D8450R00003
Sponsor:	AstraZeneca
Collaborator:	ICON plc
Start Date:	June 2024
Primary Completion Date:	June 2031
Study Completion Date:	June 2031

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

No locations posted.

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.